- Home
- Editorial
- News
- Practice Guidelines
- Anesthesiology Guidelines
- Cancer Guidelines
- Cardiac Sciences Guidelines
- Critical Care Guidelines
- Dentistry Guidelines
- Dermatology Guidelines
- Diabetes and Endo Guidelines
- Diagnostics Guidelines
- ENT Guidelines
- Featured Practice Guidelines
- Gastroenterology Guidelines
- Geriatrics Guidelines
- Medicine Guidelines
- Nephrology Guidelines
- Neurosciences Guidelines
- Obs and Gynae Guidelines
- Ophthalmology Guidelines
- Orthopaedics Guidelines
- Paediatrics Guidelines
- Psychiatry Guidelines
- Pulmonology Guidelines
- Radiology Guidelines
- Surgery Guidelines
- Urology Guidelines
Breakthrough device that will enable visually impaired to read again
NEWPORT BEACH, Calif. : Next Generation device that will enable visually impaired to read again has been launched. This wearable all-in-one virtual reality device may re-open the wearer's eyes to a world they believed forever lost due to failing sight. The NuEyes' proprietary software has paired with Pico Interactive's all-in-one Virtual Reality headset to develop this device for people with macular degeneration, glaucoma, retinitis pigmentosa, and other vision conditions. Thanks to them that they will once again be able to read, watch movies, see loved ones' faces and lead a better quality of life.
According to the World Health Organization, an estimated 285 million people across the globe suffer from some sort of vision impairment. Early age-related macular degeneration affects an estimated eight million Americans, of which more than one million will develop advanced age-related macular degeneration within the next five years. Technological innovation in visual aids has been stagnant over the last 40 years. While devices exist that can show written materials' type on a larger screen for easier readability, they lack portability and are useless for recognizing faces at a party or watching a sporting event.
In a partnership that will change the lives of millions of people, NuEyes, a pioneer in the field of low-vision technology, and Pico Interactive, maker of innovative VR solutions has developed this breakthrough device.
"I am always pleased to see new innovation for the visually impaired," said Wayne Heidle, director of community relations and assistant professor – technologist for Marshall B. Ketchum University. "Having a wearable device that offers a wide field of view, is extremely easy to use, and comfortable to wear is a big step forward. The latest wearable device from NuEyes will not disappoint."
"At NuEyes, we are extremely passionate about bringing the right innovation to market to help the visually impaired. Partnering with Pico Interactive was the clear choice for the next generation of 'Easy' products," said Mark Greget, founder/CEO NuEyes.
NuEyes Technologies Inc.
The NuEyes e2 delivers unparalleled clarity with a 3K display (1440 x 1600 screen resolution at 90hz refresh rate), 101-degree field of view, HD camera and QUALCOMM 835 snapdragon processor. Utilizing the high-definition camera, NuEyes has optimized its functionality and autofocus, which offers the consumer true colour visualization and powerful magnification up to 18x. The NuEyes software will also offer three contrast settings, optical character recognition/text-to-speech, brightness settings as well as an easy three-button configuration for convenience, flexibility, and ease of use.
"We are thrilled to work with NuEyes' innovative technology and serve the low-vision market. We're inspired by NuEyes' work and excited to help make a positive impact on people's lives," said Will Winston, partnerships manager at Pico Interactive.
The NuEyes e2 is available for pre-sale beginning on Dec. 17 at an unprecedented 50 per cent discount for 30 days only. Shipping in Q1 of 2019, the NuEyes e2 will retail for just around $2,995and during the holiday pre-sale will be available for only $1,499.
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd